• Profile
Close

Effects of oral conjugated equine estrogens with or without medroxyprogesterone acetate on incident hypertension in the womens health initiative hormone therapy trials

Menopause Jun 27, 2018

Swica Y, et al. - Researchers sought to assess the effect of menopausal hormone therapy on incident hypertension in the two Women's Health Initiative hormone therapy trials and in extended postintervention follow-up. Enrolling 27,347 postmenopausal women aged 50 to 79 years at 40 US centers, they recognized a subsample of 18,015 women who did not report hypertension at baseline and were not taking antihypertensive medication. They noted an increased risk of hypertension in association with conjugated equine estrogens (0.625 mg/d) administered orally, with or without medroxyprogesterone acetate. Further study is required to assess if lower doses, different estrogen formulations, or transdermal route of administration offer lower risks.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay